RxDoctor Payments Data

Nicole Payne, PA

Physician Assistant · Winston Salem, NCNPI 1992002190

Payments from drug & device makers

$2,907in general payments, 2019–2025

Across 145 payments — averaging $20.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Actelion Pharmaceuticals US, Inc.$519
  • Merck$450
  • Novartis$322
  • AstraZeneca$267
  • United Therapeutics Corporation$166
  • Amgen$137
  • plus $1K from 13 others

What the payments were for

  • Food & beverage$2,78896%
  • Education$1194%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,907 in reported general payments places this provider in the 85th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$24,558
Medicare patients
112
Services billed
325

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
UptraviSelexipag11$334,069
EntrestoSacubitril/Valsartan232$210,990
OpsumitMacitentan13$167,086
JardianceEmpagliflozin52$40,685
EliquisApixaban23$20,480
FarxigaDapagliflozin Propanediol21$13,731
Bumetanide67$1,931
Torsemide63$1,626
Metoprolol Succinate149$1,262
Spironolactone239$1,154
Carvedilol121$1,003
Tadalafil13$929
Furosemide152$746
Isosorbide Mononitrate ErIsosorbide Mononitrate49$367
Potassium Chloride20$282

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Actelion Pharmaceuticals US, Inc.Uptravi, Opsumit$519$501,15524 claims
NovartisEntresto$322$210,990232 claims
Boehringer IngelheimJardiance$97$40,68552 claims
PfizerEliquis$105$20,48023 claims
AstraZenecaFarxiga$267$13,73121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →